(Q53509982)

15 May 2018

title

Interleukin-17 gene expression in patients with rheumatoid arthritis. (English)

1 reference

15 May 2018

author

Mizuko Mamura

6

1 reference

15 May 2018

Takayuki Sumida

11

object named as

Takayuki Sumida

1 reference

15 May 2018

Isao Matsumoto

8

object named as

Isao Matsumoto

1 reference

15 May 2018

author name string

Mika Kohno

1

1 reference

15 May 2018

Akito Tsutsumi

2

1 reference

15 May 2018

Hiroto Matsui

3

1 reference

15 May 2018

Makoto Sugihara

4

1 reference

15 May 2018

Takeshi Suzuki

5

1 reference

15 May 2018

Daisuke Goto

7

1 reference

15 May 2018

Satoshi Ito

9

1 reference

15 May 2018

Toru Suguro

10

1 reference

15 May 2018

publication date

20 December 2007

1 reference

15 May 2018

published in

Modern Rheumatology

1 reference

15 May 2018

volume

18

1 reference

15 May 2018

issue

1

1 reference

15 May 2018

page(s)

15-22

1 reference

15 May 2018

Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease

cites work

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0015-Y

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0015-Y

Anti-interleukin-1 therapy in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0015-Y

IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0015-Y

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0015-Y

Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0015-Y

Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0015-Y

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0015-Y

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0015-Y

T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0015-Y

Treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0015-Y

Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0015-Y

10.3109/S10165-007-0015-Y

21 January 2018

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

18092129

1 reference

15 May 2018